BioRestorative Therapies (BRTX) Receivables (2015 - 2025)
BioRestorative Therapies' Receivables came in at $15,500 for Q4 2025, down 91.8% from $188,400 a year earlier but up 15.7% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Receivables (2015 - 2025) Analysis & Trends
Going back to Q2 2015, BioRestorative Therapies' Receivables data covers 41 quarters.
- Receivables carries a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- Going back by year, Receivables was $188,400 in FY2024 (+876.2%), $19,300 in FY2023 (+20.6%), $16,000 in FY2022 (+220.0%) and $5,000 in FY2021 (-70.6%).
- The five-year range for quarterly Receivables is $5,000 (Q4 2021) to $188,400 (Q4 2024).
- Year-over-year, Receivables has declined for four consecutive quarters, with growth averaging 133.4% over the last eight quarters.
- The fastest year-over-year change in Receivables over five years came in Q4 2024 (growth of 876.2%), and the weakest in Q3 2025 (a decline of 91.9%).
- Business Quant data shows BRTX's Receivables at $13,400 (Q3 2025), $15,000 (Q2 2025) and $25,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 2.13 Bn |
| 10 | BioRestorative Therapies | 1.03 Mn | -22.90 Mn | 17,964.00 | 15,500.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 15,500.00 |
| Sep 30, 2025 | 13,400.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 188,400.00 |
| Sep 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 27,400.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 19,300.00 |
| Sep 30, 2023 | 39,300.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Dec 31, 2022 | 16,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 18,000.00 |
API Access
BioRestorative Therapies Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();